Axon Therapies


Axon is an early-stage company developing a novel neuromodulation approach to treat heart failure.

Axon is an early-stage company developing a novel neuromodulation approach to treat heart failure.

Company (Alive / Active)

Phone: 212-929-6600

Fax:

315 West 36th Street

New York, 10018
New York, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Axon Therapies $3.3M Jun 28, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Axon Therapies Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors

Board Members

There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Devices and methods for treatment of heart failure by splanchnic nerve ablation Feb 05, 2016 Application